Search
for
Sort by
Research 30 of 138
- Generalized hair loss induced by indinavir plus ritonavir therapy
- Alopecia associated with ritonavir-boosted atazanavir therapy
- Alopecia induced by lopinavir plus ritonavir therapy in an HIV patient.
- SAT340 Matters Of The HAART - Ritonavir Induced CYP3A4 Inhibition of Intranasal Fluticasone Leading To Cushing’s Syndrome
- Iatrogenic Cushing Syndrome and Secondary Adrenal Insufficiency Due to an Interaction Between Fluticasone and Ritonavir
- Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?
- Hair Loss Induced by Lopinavir-Ritonavir
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- Nail, hair and skin hyperpigmentation associated with indinavir therapy
- Raltegravir-Induced Alopecia in an HIV+ Patient
- Balint’s syndrome—missed or mistaken?
- An update of anti-viral treatment of COVID-19
- Drug repositioning approach to target viral and host cells in terms of COVID-19 treatment: A review of in vivo experiments and clinical studies
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Tinea Capitis: An Overview with Emphasis on Management
- Drug Reactions Affecting Hair: Diagnosis
- Hair Loss in Women
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- Absorption sites of orally administered drugs in the small intestine
- SARS‐CoV‐2‐induced telogen effluvium: a multicentric study
- Toward a Diagnostic Score in Cushing's Syndrome
- Drug-Induced Hair Disorders
- Therapeutic Applications of Nanoemulsion Based Drug Delivery Systems: A Review of Patents in Last Two Decades
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Patients with specific skin disorders who are affected by COVID ‐19: What do experiences say about management strategies? A systematic review
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Long COVID syndrome: An unfolding enigma
- Geometric classification of scalp hair for valid drug testing, 6 more reliable than 8 hair curl groups
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Stem cell apoptosis in HIV‐1 alopecia